Risk factors for osteoradionecrosis in elderly patients with oral and pharyngeal cancer

被引:0
|
作者
Mackley, Heath [1 ]
Schaefer, Eric [2 ]
Hollenbeak, Christopher S. [3 ]
Goldenberg, David [4 ]
机构
[1] Penn State Milton S Hershey Med Ctr, Penn State Hershey Canc Inst, Div Radiat Oncol, 500 Univ Dr,CH63, Hershey, PA 17033 USA
[2] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA
[3] Penn State Milton S Hershey Med Ctr, Div Outcomes Res & Qual, Dept Surg, Hershey, PA USA
[4] Penn State Milton S Hershey Med Ctr, Div Otolaryngol, Dept Surg, Hershey, PA USA
基金
美国国家卫生研究院;
关键词
Osteoradionecrosis; Oral cancer; Pharyngeal cancer; Radiotherapy; SEER analysis;
D O I
10.1007/s13566-013-0117-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Osteoradionecrosis (ORN) is a serious complication of radiation therapy used in the treatment of squamous cell carcinoma of the oral cavity and pharynx. The incidences reported in clinical series have varied significantly. In this study, we estimate the incidence of ORN and evaluate the variables associated with developing ORN using the SEERMedicare database. Methods Our analysis was limited to patients who were >= 66 years of age. ORN was identified using Medicare billing records. We estimated the incidence of ORN in the presence of mortality as a competing risk using the cumulative incidence function, controlling for available patient, disease, and treatment characteristics. Risk factors for ORN were identified using the competing risks regression model of Fine and Gray. Results Two hundred and twenty one of the 5,390 patients developed ORN, representing a crude incidence rate of 4.1 % (95 % CI, 3.6 to 4.7 %). At 1, 2, 5, and 10 years, the incidence of ORN was 1.4, 2.4, 4.1, and 5.9 %. Oral cavity primary (hazard ratio (HR)= 2.67, p < 0.001), multimodality treatment (HR= 1.39, p = 0.04), decreased age (HR= 0.59, p < 0.001), female gender (HR= 0.61, p < 0.001), and stage (HR= 0.43, p = 0.008) were associated with the development of ORN, but only oral cavity primary was not associated with a decreased risk of mortality, showing that mortality is a strong competing risk for ORN. Conclusion The incidence of ORN continues to increase steadily up to 10 years from the time of diagnosis. Patients with oral cavity primaries are at highest risk in this population. Future research should be directed toward identifying factors that can reduce the incidence of ORN.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 50 条
  • [31] DIETARY GLUTATHIONE INTAKE AND THE RISK OF ORAL AND PHARYNGEAL CANCER
    FLAGG, EW
    COATES, RJ
    JONES, DP
    BYERS, TE
    GREENBERG, RS
    GRIDLEY, G
    MCLAUGHLIN, JK
    BLOT, WJ
    HABER, M
    PRESTONMARTIN, S
    SCHOENBERG, JB
    AUSTIN, DF
    FRAUMENI, JF
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (05) : 453 - 465
  • [32] Fiber intake and the risk of oral, pharyngeal and esophageal cancer
    Soler, M
    Bosetti, C
    Franceschi, S
    Negri, E
    Zambon, P
    Talamini, R
    Conti, E
    La Vecchia, C
    INTERNATIONAL JOURNAL OF CANCER, 2001, 91 (03) : 283 - 287
  • [33] The role of a Mediterranean diet on the risk of oral and pharyngeal cancer
    M Filomeno
    C Bosetti
    W Garavello
    F Levi
    C Galeone
    E Negri
    C La Vecchia
    British Journal of Cancer, 2014, 111 : 981 - 986
  • [34] SERUM MICRONUTRIENTS AND THE SUBSEQUENT RISK OF ORAL AND PHARYNGEAL CANCER
    ZHENG, W
    BLOT, WJ
    DIAMOND, EL
    NORKUS, EP
    SPATE, V
    MORRIS, JS
    COMSTOCK, GW
    CANCER RESEARCH, 1993, 53 (04) : 795 - 798
  • [35] Risk Factors for Polypharmacy in Elderly Patients With Cancer Pain
    Morio, Kayoko
    Maeda, Isseki
    Yokota, Isao
    Niki, Kazuyuki
    Murata, Taizo
    Matsumura, Yasushi
    Uejima, Etsuko
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2019, 36 (07): : 598 - 602
  • [36] Osteoradionecrosis After Mandibulotomy and Marginal Mandibulectomy in Patients With Oral Cancer
    Wongmanee, Sombat
    Chotipanich, Adit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [37] Osteoradionecrosis of mandible bone in patients with oral cancerassociated factors and treatment outcomes
    Chen, Jyun-An
    Wang, Chen-Chi
    Wong, Yong-Kie
    Wang, Ching-Ping
    Jiang, Rong-San
    Lin, Jin-Ching
    Chen, Chien-Chih
    Liu, Shih-An
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (05): : 762 - 768
  • [38] Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer
    Raguse, Jan-Dirk
    Hossamo, Jaber
    Tinhofer, Ingeborg
    Hoffmeister, Bodo
    Budach, Volker
    Jamil, Basil
    Joehrens, Korinna
    Thieme, Nadine
    Doll, Christian
    Nahles, Susanne
    Hartwig, Stefan T.
    Stromberger, Carmen
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2016, 121 (03): : 215 - U187
  • [39] Risk factors and dose-effect relationship for osteoradionecrosis after hyperfractionated and conventionally fractionated radiotherapy for oral cancer
    Niewald, M
    Barbie, O
    Schnabel, K
    Engel, M
    Schedler, M
    Nieder, C
    Berberich, W
    BRITISH JOURNAL OF RADIOLOGY, 1996, 69 (825): : 847 - 851
  • [40] A Case Series Study Analysing the Risk Factors in the Incidence of Osteoradionecrosis in Head and Neck Cancer Patients
    Iqbal, Z.
    Kyzas, P.
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 110 - 110